In a new column, Dr. Drew Altman, KFF's Founding President and CEO, previews findings about the chronically ill uninsured from a large KFF survey of 25,000 Americans focusing on the cost and access ch...

For the fourth in his “Untold KFF History” series, KFF’s Founding President and CEO Dr. Drew Altman discusses KFF’s polling partnerships with major news organizations—a practice that began with the Wa...

For the third in his “Untold KFF History” series, KFF’s Founding President and CEO Dr. Drew Altman discusses an ambitious and relatively short-term effort, the Global Media AIDS Initiative, which was ...

In a new column that analyzes recent KFF polling, Founding President and CEO Dr. Drew Altman concludes that only a sliver of the public hold definitive anti-science, anti-vaccine views, and are greatl...

Dr. Altman has led the organization for nearly 40 years; Levitt and Dr. Brodie to assume leadership roles next year, after a combined six decades at KFF in senior positions guiding policy research and...

In a new column, Dr. Drew Altman, Founding President and CEO, dissects the MAHA “movement.” He writes: “There appear to be many MAHAs, not one. You can care about pesticides, or food additives, or vac...

In a new column, Dr. Drew Altman, Founding President and CEO, dissects the MAHA “movement.” He writes: “There appear to be many MAHAs, not one. You can care about pesticides, or food additives, or vac...

Asked for a one-pager on what's wrong with the U.S. health system, Dr. Drew Altman, Founding President and CEO, explains the top issues in this piece, published today as his latest column. Altman expl...

A new column on the uninsured from President and CEO Dr. Drew Altman explains: “The uninsured is not the most politically salient problem in health care now, that’s affordability, nor is it the non-problem some say it is. But it’s coming back. And the problem of the chronically ill uninsured is glaring.” Read more.

Americans say they worry most about healthcare among 16 domestic issues, followed by the economy, inflation, the federal budget and income inequality.

This poll finds that about as many adults are turning to AI for health information as social media, with health care costs and access driving many users, particularly younger users.

In a new column, Dr. Drew Altman, KFF’s President and CEO, discusses the impact of the war in Iran and rising gas prices on voter concerns about health care costs. He writes: “Recently, we saw health ...

In his latest column, President and CEO Dr. Drew Altman asks if prior authorization review could be eliminated entirely, discussing how it might be done and the tradeoffs.

In his latest column, President and CEO Dr. Drew Altman presents his Venn diagram of health care cost problems and shows how, in our fragmented health system, reducing one health cost problem often ma...

This brief describes current state fiscal conditions as states begin fiscal year 2027 budget debates and highlights key areas to watch for Medicaid policy changes as states respond to fiscal challenge...

CALLING ON CONGRESS TO LOWER HEALTHCARE COSTS: Today, President Donald J. Trump called on Congress to enact the Great Healthcare Plan, a comprehensive

In his first column for the new year, KFF CEO Dr. Drew Altman analyzes President Trump’s “make a deal” approach to health care. He explains that while the president doesn’t have a health reform plan, ...

This policy watch evaluates state awards through the rural health fund in 2026, the first year of the program. The analysis shows relatively modest variations in total awards this year across states b...

If the amount they pay in premiums doubled, about one in three enrollees in Affordable Care Act Marketplace health plans say they would be “very likely” to look for a lower-premium Marketplace plan (w...

Prior authorization review frustrates patients and physicians, but we likely can’t just eliminate it. In his new column, President and CEO Dr. Drew Altman discusses why, and why the focus is now inste...

Prior to the Affordable Care Act (ACA), insurers selling coverage to individuals would deny people with serious pre-existing conditions and high-risk occupations, exclude coverage for certain services...

The surprisingly tricky question stumped researchers for decades. But they think they finally have an answer.

In Mississippi, a state with one of the highest obesity rates in the nation, Medicaid covers weight loss drugs, but few enrollees have signed up for the benefit.